Education
About Us
Working with TipRanks
Follow Us
Taiko Pharmaceutical Co., Ltd. (JP:4574)
:4574
Total Valuation
Taiko Pharmaceutical Co., Ltd. has a market cap or net worth of ¥12.17B. The enterprise value is ¥19.63B.
Market Cap¥12.17B
Enterprise Value¥19.63B
Share Statistics
Taiko Pharmaceutical Co., Ltd. has 50,636,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding50,636,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Taiko Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 8.85%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)8.85%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee29.40M
Profits Per Employee4.20M
Employee Count214
Asset Turnover0.49
Inventory Turnover1.57
Valuation Ratios
The current PE Ratio of Taiko Pharmaceutical Co., Ltd. is 18.50. Taiko Pharmaceutical Co., Ltd.’s PEG ratio is 0.68.
PE Ratio18.50
PS Ratio0.00
PB Ratio1.53
Price to Fair Value2.09
Price to FCF21.56
Price to Operating Cash Flow15.33
PEG Ratio0.68
Income Statement
In the last 12 months, Taiko Pharmaceutical Co., Ltd. had revenue of 6.29B and earned 898.00M in profits. Earnings per share was 17.89.
Revenue6.29B
Gross Profit3.67B
Operating Income629.00M
Pretax Income565.00M
Net Income898.00M
EBITDA882.00M
Earnings Per Share (EPS)17.89
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Taiko Pharmaceutical Co., Ltd. pays an annual dividend of ¥10, resulting in a dividend yield of ―
Dividend Per Share¥10
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.89
52-Week Price Change-38.94%
50-Day Moving Average260.98
200-Day Moving Average326.93
Relative Strength Index (RSI)35.84
Average Volume (3m)210.27K
Important Dates
Taiko Pharmaceutical Co., Ltd. upcoming earnings date is Aug 8, 2025, TBA Not Confirmed.
Last Earnings DateMay 9, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend DateDec 29, 2020
Financial Position
Taiko Pharmaceutical Co., Ltd. as a current ratio of 3.07, with Debt / Equity ratio of 0.32%
Current Ratio3.07
Quick Ratio2.48
Debt to Market Cap0.12
Net Debt to EBITDA-2.84
Interest Coverage Ratio78.63
Taxes
In the past 12 months, Taiko Pharmaceutical Co., Ltd. has paid -332.00M in taxes.
Income Tax-332.00M
Effective Tax Rate-0.59
Enterprise Valuation
Taiko Pharmaceutical Co., Ltd. EV to EBITDA ratio is 15.99, with an EV/FCF ratio of 68.81.
EV to Sales2.24
EV to EBITDA15.99
EV to Free Cash Flow68.81
EV to Operating Cash Flow38.97
Balance Sheet
Taiko Pharmaceutical Co., Ltd. has ¥4.53B in cash and marketable securities with ¥2.03B in debt, giving a net cash position of -¥2.50B billion.
Cash & Marketable Securities¥4.53B
Total Debt¥2.03B
Net Cash-¥2.50B
Net Cash Per Share-¥49.47
Tangible Book Value Per Share¥158.12
Margins
Gross margin is 69.01%, with operating margin of 10.00%, and net profit margin of 14.27%.
Gross Margin69.01%
Operating Margin10.00%
Pretax Margin8.98%
Net Profit Margin14.27%
EBITDA Margin14.02%
EBIT Margin9.95%
Analyst Forecast
The average price target for Taiko Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―